Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Henrik Ekman

Equity Research Analyst

Henrik Ekman portrait

Coverage

Zerion PharmaQlife Holding

Latest content

ShowingAll content types

Gubra: Interview med CEO Henrik Blou post Q2 og opjustering af finansiel guidance for 2024

Analyst Comment 26.08.2024, 08.35 by Henrik Ekman, Claus Thestrup
Gubra

Ascelia Pharma: Wrap up from interview with Deputy CEO Julie Waras Brogren

Analyst Comment 20.08.2024, 08.25 by Claus Thestrup, Henrik Ekman
Ascelia Pharma

Pharma Equity Group: Interview med CEO Thomas Kaas Selsø ifm aflæggelse af halvårsregnskab 2024

Video 18.08.2024, 18.42 by Claus Thestrup, Henrik Ekman
Pharma Equity Group

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account

Bioporto: Interview med CEO Peter M. Eriksen

Video 16.08.2024, 08.30 by Claus Thestrup, Henrik Ekman
BioPorto

BioPorto: Potential for labelling expansion of NGAL test

Analyst Comment 08.08.2024, 11.16 by Claus Thestrup, Henrik Ekman
BioPorto

Gubra: Share price moves to all-time high as another partner project enters phase 1

Analyst Comment 02.07.2024, 08.06 by Henrik Ekman, Claus Thestrup
Gubra

Curasight: Management remains confident on its strategy as new financing plan is launched

Analyst Comment 27.06.2024, 08.38 by Henrik Ekman, Claus Thestrup
Curasight

Ascelia Pharma: Wrap up from interview with Deputy CEO Julia Waras Brogren

Analyst Comment 18.06.2024, 10.48 by Claus Thestrup, Henrik Ekman
Ascelia Pharma

ALK: Wrap up fra interview med CFO Claus Steensen Søjle og IR Per Plotnikov

Analyst Comment 14.06.2024, 07.48 by Henrik Ekman, Claus Thestrup
ALK-Abelló

HCA Capital: Wrap up from 2024 Life Science seminar

Analyst Comment 06.06.2024, 11.32 by Henrik Ekman, Claus Thestrup
Ascelia PharmaGubraBioPortoPharma Equity Group
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.